Wave Life Sciences Ltd. - Ordinary Shares (WVE): Price and Financial Metrics
Wave Life Sciences Ltd. - Ordinary Shares (WVE)
Today's Latest Price: $19.09 USD
Updated Sep 17 4:00pm
Add WVE to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 232 in Medical - Pharmaceuticals
See all "A" rated Strong Buy stocks
WVE Stock Summary
- Wave Life Sciences Ltd's capital turnover -- a measure of revenue relative to shareholder's equity -- is better than only 3.32% of US listed stocks.
- With a price/sales ratio of 55.6, Wave Life Sciences Ltd has a higher such ratio than 95.99% of stocks in our set.
- Revenue growth over the past 12 months for Wave Life Sciences Ltd comes in at -33.3%, a number that bests only 6.92% of the US stocks we're tracking.
- If you're looking for stocks that are quantitatively similar to Wave Life Sciences Ltd, a group of peers worth examining would be MCRB, VBLT, KALV, NTLA, and IMGN.
- WVE's SEC filings can be seen here. And to visit Wave Life Sciences Ltd's official web site, go to www.wavelifesciences.com.
WVE Stock Price Chart Technical Analysis Charts
WVE Price/Volume Stats
| Current price | $19.09 | 52-week high | $39.98 |
| Prev. close | $17.71 | 52-week low | $6.61 |
| Day low | $16.83 | Volume | 1,607,573 |
| Day high | $19.88 | Avg. volume | 632,339 |
| 50-day MA | $10.90 | Dividend yield | N/A |
| 200-day MA | $10.93 | Market Cap | 695.91M |
Wave Life Sciences Ltd. - Ordinary Shares (WVE) Company Bio
WAVE Life Sciences Pte. Ltd., a preclinical biopharmaceutical company, designs, develops, and commercializes nucleic acid therapeutic candidates. The company was founded in 2012 and is based in Simgapore.
Loading social stream, please wait...